# Levofloxacin

NDC: 0409-2220
Generic name: Levofloxacin
Labeler / Manufacturer: Hospira, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20240520

FDA application: ANDA090343

## Active ingredients

- LEVOFLOXACIN: 250 mg/50mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0409-2220"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0409-2220
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5a1534af-aa1c-4f1d-ba9f-9415b14e1af2